价格

mRNA based therapeutics

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

DEUTERIUM-STABILISED RIBONUCLEIC ACID (RNA) MOLECULES DISPLAYING INCREASED RESISTANCE TO THERMAL AND ENZYMATIC HYDROLYSIS, AQUEOUS COMPOSITIONS COMPRISING STABILIZED RNA MOLECULES AND METHODS FOR MAKING SAME
EP 4244351 A4申请人: DEUTRAMED SOLUTIONS LTD优先权: 2020
EP
US
WO
5 件公开
METHOD FOR ENHANCING IMMUNITY
EP 4514387 A4申请人: XANADU BIO INC优先权: 2022
EP
US
WO
3 件公开
Methods for therapeutic administration of messenger ribonucleic acid drugs
US 10849920 B2申请人: MODERNATX INC优先权: 2016
US
3 件公开
DELIVERY OF GENE EDITING SYSTEMS AND METHODS OF USE THEREOF
EP 4680287 A1申请人: RENAGADE THERAPEUTICS MAN INC优先权: 2023
EP
WO
2 件公开
LIPID NANOPARTICLES COMPRISING CODING RNA MOLECULES FOR USE IN GENE EDITING AND AS VACCINES AND THERAPEUTIC AGENTS
- EP 4680595 A2
  申请人: RENAGADE THERAPEUTICS MAN INC优先权: 2023
  EP
  WO
  2 件公开
- EP 4731601 A1
  申请人: RENAGADE THERAPEUTICS MAN INC优先权: 2023
  EP
  WO
  2 件公开
- WO 2025128871 A3
  申请人: RENAGADE THERAPEUTICS MAN INC优先权: 2023
  WO
- WO 2025174765 A1
  申请人: RENAGADE THERAPEUTICS MAN INC优先权: 2024
  WO
LIPID NANOPARTICLES AND METHODS OF MANUFACTURE AND USE THEREOF
US 20260137803 A1申请人: GENZYME CORP优先权: 2024
US
WO
2 件公开
Use of interleukin 10 mRNA transfected macrophages in anti-inflammatory therapies
US 9315558 B2申请人: KAYA ZIYA优先权: 2010
US
2 件公开
MODIFIED U7 SNRNAS FOR TREATMENT OF NEUROMUSCULAR DISEASES
US 2013045538 A1申请人: ASS INST DE MYOLOGIE优先权: 2011
US
2 件公开
COMPOSITION FOR DELIVERING MODIFIED NUCLEIC ACID-CONTAINING MRNA
EP 4356933 A1申请人: EYEGENE INC优先权: 2022
EP
LUNG-SPECIFIC MRNA DELIVERY ENABLED BY SULFONIUM LIPID NANOPARTICLES
WO 2025189135 A8申请人: UNIV NEW YORK STATE RES FOUND优先权: 2024
WO

药物

mRNA based therapeutics

专利

LIPID NANOPARTICLES COMPRISING CODING RNA MOLECULES FOR USE IN GENE EDITING AND AS VACCINES AND THERAPEUTIC AGENTS